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Sequestration of cholesterol within the host late 
endocytic pathway restricts liver-stage 
Plasmodium development
ABSTRACT While lysosomes are degradative compartments and one of the defenses against 
invading pathogens, they are also hubs of metabolic activity. Late endocytic compartments 
accumulate around Plasmodium berghei liver-stage parasites during development, and 
whether this is a host defense strategy or active recruitment by the parasites is unknown. In 
support of the latter hypothesis, we observed that the recruitment of host late endosomes 
(LEs) and lysosomes is reduced in uis4− parasites, which lack a parasitophorous vacuole mem-
brane protein and arrest during liver-stage development. Analysis of parasite development in 
host cells deficient for late endosomal or lysosomal proteins revealed that the Niemann–Pick 
type C (NPC) proteins, which are involved in cholesterol export from LEs, and the lysosome-
associated membrane proteins (LAMP) 1 and 2 are important for robust liver-stage P. berghei 
growth. Using the compound U18666A, which leads to cholesterol sequestration in LEs simi-
lar to that seen in NPC- and LAMP-deficient cells, we show that the restriction of parasite 
growth depends on cholesterol sequestration and that targeting this process can reduce 
parasite burden in vivo. Taken together, these data reveal that proper LE and lysosome func-
tion positively contributes to liver-stage Plasmodium development. 
INTRODUCTION
Although many intracellular pathogens encounter, or even exploit, 
the host endocytic pathway upon invasion, apicomplexan parasites 
avoid the endocytic pathway upon entry through their active inva-
sion of cells (Sibley, 2011). Recent studies of Plasmodium berghei 
parasites, however, found that late endosomes (LEs) and lysosomes 
of the host progressively accumulate around the parasitophorous 
vacuole (PV) and associated tubovesicular network (TVN) during the 
first 24 h of parasite liver-stage development (Lopes da Silva et al., 
2012; Grützke et al., 2014). The mechanisms and consequences of 
this recruitment are thus far undefined.
After development within hepatocytes, Plasmodium parasites 
infect red blood cells and cause malaria. Although red blood cells 
have minimal resources available to the parasites, blood-stage Plas-
modium are well adapted to take advantage of their host environ-
ment, for example, through the metabolism of host hemoglobin 
(Sigala and Goldberg, 2014). Hepatocytes as host cells could offer 
more opportunities for parasites to usurp host processes but could 
also present a greater chance of encountering cellular defense path-
ways. Fusion of the liver-stage PV with host lysosomes can act as 
one of these defense pathways and lead to parasite killing (Prado 
et al., 2015; Boonhok et al., 2016); however, for the majority of 
liver-stage parasites, any fusion of the host late endocytic compart-
ments with the PV membrane (PVM) is minimal because markers 
of LEs and lysosomes such as CD63 and lysosome-associated 
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PVM proteins and investigated the influ-
ence of late endosomal host proteins on 
parasite development. We analyzed para-
site development within cells deficient for 
the late endosomal/lysosomal proteins Nie-
mann–Pick type C (NPC) 1 and 2, LAMP1, 
and LAMP2. The prominent phenotypes of 
cells deficient for these proteins include de-
fects in autophagic flux and the accumula-
tion of cholesterol in LEs and lysosomes due 
to inefficient export of free cholesterol from 
these vesicles (Eskelinen et al., 2004; Chang 
et al., 2005; Schneede et al., 2011). In the 
present model, endocytosed cholesteryl es-
ters are hydrolyzed upon reaching LEs, and 
the resulting unesterified cholesterol in the 
lysosomal lumen is initially bound by NPC2, 
and subsequently transferred to NPC1 in 
the limiting LE/lysosomal membrane (Wang 
et al., 2010). Cells deficient for LAMP1 and 
LAMP2 phenocopy the defects observed in 
cells deficient for either NPC1 or NPC2, in-
dicating that these two type I transmem-
brane glycoproteins are also required for 
proper export of cholesterol out of LEs and 
lysosomes (Schneede et al., 2011).
Plasmodium is unable to synthesize cho-
lesterol de novo, but the parasite PVM is 
enriched with cholesterol (Bano et al., 2007). 
Although Plasmodium can access cholesterol 
from the host via either the endogenous or 
exogenous pathways (Labaied et al., 2011), 
neither pathway has been shown to be neces-
sary for parasite growth, and the significance 
of this cholesterol acquisition for Plasmodium 
liver-stage development is undetermined.
RESULTS
Efficient recruitment of host late endocytic compartments 
requires UIS4
The striking recruitment of host LEs and lysosomes to developing 
P. berghei liver-stage parasites (Lopes da Silva et al., 2012; Supple-
mental Figure S1A) and to the liver-stage TVN (Grützke et al., 2014) 
prompted us to investigate whether parasite PVM/TVN proteins play 
a role in recruitment of these vesicles. We tested recombinant para-
site lines deficient for the proteins UIS4 (Mueller et al., 2005) and 
IBIS1 (Ingmundson et al., 2012) for their capacity to recruit late endo-
cytic compartments (Figure 1, A and B). Both UIS4 and IBIS1 are 
transmembrane P. berghei-encoded proteins that localize to the 
liver-stage PVM/TVN. Although absence of IBIS1 does not appear to 
affect liver-stage growth (Ingmundson et al., 2012; Supplemental 
Figure S2A), infection with uis4− parasites results in reduced parasite 
burden in the liver and liver-stage arrest (Mueller et al., 2005; Supple-
mental Figure S2A). In vitro, uis4− parasites are less likely to success-
fully develop into liver-stage forms (Mueller et al., 2005; Supplemen-
tal Figure S2B), although those that do develop are approximately 
the same size as wild-type parasites (Supplemental Figure S2C). We 
confirmed the absence of UIS4 in these parasites with antibody 
staining of infected cells (Supplemental Figure S2D).
Although ibis1− parasites recruited LEs at a frequency compara-
ble to wild-type parasites, noticeably fewer uis4− parasites were sur-
rounded by CD63-positive vacuoles 24 h after infection. By assessing 
of the PV, and the PV does not have the acidity of lysosomes (Lopes 
da Silva et al., 2012; Grützke et al., 2014; Prado et al., 2015).
The PV interacts directly with the host autophagy pathway, as 
seen by the recruitment of the autophagy protein LC3 to the devel-
oping parasite (Grützke et al., 2014; Prado et al., 2015; Thieleke-
Matos et al., 2016). Typically, autophagosome maturation results in 
fusion with lysosomes, and some of the lysosomes associated with 
the PV also possess the autophagy marker LC3; however, the PV of 
properly developing parasites does not appear to mature as an au-
tophagosome beyond LC3 recruitment, and further maturation 
seems detrimental to the parasites (Prado et al., 2015). Some of the 
late endocytic vesicles surrounding the PV do possess both LC3 and 
lysosomal markers, indicating that some of these associated vesicles 
are maturing amphisomes (Thieleke-Matos et al., 2016). Parasite-en-
coded proteins within the liver-stage PVM and TVN are at the inter-
face between the parasite and host and likely play a critical role in the 
interaction with the host cell and its organelles. For instance, the liver 
stage–specific protein up-regulated in infective sporozoites 4 (UIS4) 
delineates the PVM, and reverse genetics established the necessity 
of this PVM protein for parasite maturation inside the liver (Mueller 
et al., 2005), but the underlying molecular mechanism that leads to 
growth restriction in the absence of UIS4 remains enigmatic.
To elucidate the function and mechanism of late endocytic or-
ganelle recruitment to liver stage parasites, we assessed this recruit-
ment upon infection with parasites deficient for specific parasite 
FIGURE 1: UIS4 is required for maximal host LE and cholesterol recruitment to developing 
liver-stage P. berghei parasites. (A–C) Huh7 cells infected with GFP-expressing wild-type (WT), 
uis4−, or ibis1− parasites were fixed 24 h postinfection and stained with filipin (blue) and 
antibodies against CD63 (red) and GFP (green). Scale bars, 10 μm. (D) Huh7 cells were infected 
with P. berghei WT or mutant sporozoites, and infection was left to proceed until the indicated 
time points. Samples were stained with anti-GFP (parasite) and either anti-CD63 (LE/lysosomes; 
(top), anti-LAMP2 (LE/lysosomes; middle), or anti-LC3 (autophagic bodies; bottom). (E) WT and 
Atg5−/− MEFs infected with P. berghei sporozoites were fixed 24 h postinfection and stained with 
antibodies against PbHsp70 (parasite) and LAMP2 (LE/lysosomes). At least 50 parasites per well 
were scored for host marker recruitment. Results are shown as a mean percentage of total 
parasites analyzed per well (±SD). One representative experiment of three performed is shown. 
ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001 (Fisher’s exact test).
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LE recruitment to parasites over time from soon after host cell inva-
sion until the beginning of merosome development, we saw that the 
percentage of uis4− parasites that recruit LEs was at least 34% lower 
than that of wild-type parasites throughout infection (Figure 1C). 
The same pattern was observed in uis4−-infected cells stained with 
the LE and lysosome marker LAMP2 (Figure 1C).
Other known host components that have been shown to be as-
sociated with the liver-stage PVM are cholesterol and the autophagy 
protein LC3 (Labaied et al., 2011; Grützke et al., 2014; Prado et al., 
2015). As previously reported, membranes surrounding liver-stage 
parasites are enriched with cholesterol, as detected by filipin stain-
ing (Labaied et al., 2011). When cells are infected with uis4− para-
sites, this enrichment of the PVM with cholesterol is detected less 
frequently (Figure 1, A and C), and when it is detected, the intensity 
of filipin staining surrounding parasites is typically less than around 
wild-type parasites (Supplemental Figure S2, E and F).
Furthermore, UIS4-deficient parasites recruit LC3 less efficiently 
than wild-type parasites when LC3 localization is examined over the 
course of infection (Figure 1C and Supplemental Figure S2G). Au-
tophagosome maturation is associated with lysosome fusion. There-
fore we assessed whether recruitment of lysosomes to the PVM 
depends on LC3 recruitment by examining recruitment of LAMP2-
positive vesicles to liver-stage parasites in Atg5−/− cells, which are 
not capable of LC3 processing and lipidation (Kuma et al., 2004) 
and do not allow LC3 recruitment to developing parasites (Prado 
et al., 2015). Lysosome accumulation around liver-stage parasites 
does not depend on LC3 recruitment: no significant difference in 
LAMP2-vesicle association to parasites was seen in Atg5−/− cells 
compared with wild-type cells (Figure 1D). Therefore absence of 
LC3 around uis4− parasites is not directly responsible for the lack of 
recruited late endocytic vesicles. These results demonstrate that the 
absence of UIS4 on the PVM negatively affects the recruitment of 
host lysosomes and host cholesterol during liver-stage develop-
ment. Although this result might be an indirect consequence of in-
complete vacuole development of uis4− parasites rather than a di-
rect interaction of UIS4 with the host endocytic pathway, the 
correlation between arrested growth and reduced LE and lysosome 
recruitment in uis4− parasites indicates that the recruitment of host 
late endocytic compartments signifies proper liver-stage develop-
ment and might be of benefit to developing parasites.
Cells deficient for LAMP or NPC proteins fail to support 
efficient liver-stage parasite development
To begin to ascertain which host lyososomal functions could contrib-
ute to liver-stage parasite development, we infected embryonic fibro-
blasts (MEFs) derived from knockout mouse lines lacking specific 
lysosomal proteins (Scimeca et al., 2000; Eskelinen et al., 2004; 
Huang et al., 2014; Kissing et al., 2015). Because mouse embryonic 
fibroblasts are not a natural target cell for Plasmodium sporozoite 
infection, we wanted to ensure that these cells support normal para-
site development. A comparison of parasite growth in hepatoma 
(Huh7) and wild-type MEFs showed that, although parasite numbers 
are in general lower in MEFs (unpublished data), once sporozoites 
establish infection, they develop into similarly sized liver-stage forms 
as in Huh7 cells (Supplemental Figure S3A). These data, together 
with successful merosome production (see Figure 3B later in this 
article), suggest that MEFs are a suitable model cell line for Plasmo-
dium infection and development. MEFs deficient for the vacuolar 
ATPase subunit V0A3 (Scimeca et al., 2000) or V-ATPase accessory 
protein ATP6AP2 (Kissing et al., 2015) support P. berghei liver-stage 
growth as well as the comparable wild-type cell lines (Figure 2, A 
and B). These findings indicate that these proteins are dispensable 
FIGURE 2: Host proteins involved in lipid export from late endocytic 
vacuoles are important for P. berghei development. (A–D) MEF cell 
lines deficient for late endocytic/lysosomal host proteins and 
corresponding WT MEFs were infected with P. berghei sporozoites, 
and parasite size was assessed by fluorescence microscopy 24 h 
postinfection. In all experiments, parasites were visualized by staining 
with anti-PbHsp70 antibody. One representative experiment of 
at least three performed is shown. ns, not significant; **p < 0.01; 
***p < 0.001 (Student’s unpaired t test, n = 3).
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embryos, they are prone to clonal differ-
ences. To further support our findings, we 
tested P. berghei growth in a second, inde-
pendently generated LAMP1/LAMP2-defi-
cient cell line. Parasite growth was similarly 
restricted in this second clone in compari-
son to the congenic wild-type line (Supple-
mental Figure S3, B and C).
Of note, the percentage of infected 
cells differed between wild-type and knock-
out MEF in the two LAMP1/LAMP2-defi-
cient cell lines. Lamp1−/−Lamp2−/− cells of 
clone 1, but not clone 2, harbored more 
parasites after infection than wild-type con-
trol cell lines (unpublished data), indicating 
that infection rates can differ between MEF 
lines but cannot be attributed to loss of 
LAMP1 and LAMP2.
The impaired parasite growth in Lamp1−/− 
Lamp2−/− cells led to reduced production of 
merosomes (Figure 3B), the final stage of 
liver development, in which parasites are re-
leased (Sturm et al., 2006). Merosome num-
bers were reduced by >60% in knockout 
cells compared with wild-type MEFs. Be-
cause of the higher number of infected cells 
in Lamp1−/−Lamp2−/− cells, these results indi-
cate that formation of first-generation mero-
zoites is severely impaired in cells lacking 
LAMP1 and LAMP2.
To confirm independently the data we 
generated in the Lamp1−/−Lamp2−/− MEFs 
and address whether both LAMP proteins 
are similarly important for parasite develop-
ment, we used small interfering RNA 
(siRNA) to target LAMP1 and LAMP2 ex-
pression individually. Gene expression was 
targeted with at least three distinct siRNA 
sequences (A–C) against either Lamp1 or 
Lamp2, and each siRNA was transfected in-
dividually into hepatoma cells. Using anti-
bodies against LAMP1 or LAMP2, we confirmed efficient knock-
down for all three siRNAs targeting Lamp1 and for siRNA A and B 
but not siRNA C targeting Lamp2 (Figure 3C). When the cells were 
infected, only siRNAs that reduced protein expression of LAMP2 
caused significant reductions in parasite size (Figure 3D). Despite 
efficient knockdown of LAMP1, no effect on parasite development 
was observed. When LAMP2 knockdown was not achieved (siRNA 
C), parasite size was comparable to that for infected control cells. 
Combining LAMP1 knockdown with LAMP2 knockdown did not 
further enhance the phenotype (unpublished data). We conclude 
that LAMP2 expression is crucial for efficient parasite liver-stage 
development.
Sequestration of cholesterol in late endocytic vesicles 
restricts liver-stage growth
To validate the parasite growth phenotype observed in NPC- and 
LAMP-deficient cells, we used the amphipathic steroid 3-b-[2-
(diethylamine)eth-oxy]androst-5-en-17-one (U18666A), which is 
well established to mimic the cellular phenotype caused by Npc 
mutations (Cenedella, 2009; Lu et al., 2015). U18666A blocks the 
exit of low-density lipoprotein (LDL)–derived free cholesterol from 
for liver-stage maturation. In contrast, parasites developing within 
cells deficient for the lysosomal glycoproteins LAMP1 and LAMP2 
were significantly smaller 24 h after sporozoite infection than those 
growing in wild-type cells (Figure 2C). Parasite growth was similarly 
restricted in cells lacking the NPC1 and NPC2; Figure 2D).
One phenotype shared by both cell lines in which reduced 
parasite growth was observed is the accumulation of cholesterol 
in LEs (Liscum, 2000; Eskelinen et al., 2004). One important func-
tion of late endocytic organelles lies in the processing and sorting 
of exogenously derived cholesterol, and deletion of Npc1, Npc2, 
or Lamp1 and Lamp2 blocks the export of free cholesterol from 
LEs (Brasaemle and Attie, 1990; Liscum, 2000; Eskelinen et al., 
2004).
To determine the effect of cholesterol retention in LEs on infec-
tion outcome, we followed infection of Lamp1−/−Lamp2−/− cells until 
parasite egress. At 48 h after infection, the difference in parasite size 
between control and knockout cell lines was even more severe than 
at 24 h (Figure 3A). Parasites in control cells increased in size by 
more than sevenfold from 24 to 48 h, whereas parasites in LAMP1/
LAMP2-deficient cells increased by only approximately fourfold. Be-
cause MEF cell lines are derived from individual embyronic day 12.5 
FIGURE 3: Host LAMP1 and LAMP2 are required for efficient P. berghei liver-stage 
development. (A, B) WT and Lamp1−/−Lamp2−/− MEFs were infected with P. berghei sporozoites. 
Parasite size was assessed 48 h postinfection (A; right, representative images of mean-sized 
parasites), and the total number of merosomes was counted 70 h postinfection (B). (C) Protein 
levels of LAMP1 or LAMP2 in Huh7 cells transfected with siRNAs targeting either Lamp1 or 
Lamp2 were evaluated by Western blotting 48 h after transfection. The effect of three 
independent siRNAs (A–C) targeting Lamp1 or Lamp2 were compared with a nonspecific 
negative control siRNA (neg) using antibodies against LAMP1 or LAMP2, respectively. 
(D) siRNA-transfected cells were infected with P. berghei sporozoites 48 h posttransfection, and 
parasite size was evaluated 48 h postinfection. Parasites were visualized with anti-PbHsp70 
antibody. One representative of at least three independent experiments is shown. ns, not 
significant; *p < 0.05; **p < 0.01 (Student’s unpaired t test, n = 3).
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detected by filipin, accumulates in enlarged 
intracellular vacuoles (Figure 5A and Sup-
plemental Figure S4C). With the addition of 
1 mM MβCD, lysosomal morphology was 
restored, and filipin labeled the plasma 
membrane, similar to control cells. Addition 
of MβCD also rescued the effect on parasite 
size caused by U18666A (Figure 5B). Para-
sites developing in cells treated with both 
U18666A and MβCD were significantly 
larger than those growing in cells treated 
with U18666A alone. MβCD treatment 
alone does not alter parasite growth, indi-
cating that the drug at this concentration 
has no effect on parasite development.
Together these data demonstrate that 
cholesterol accumulation in host LEs and ly-
sosomes impairs parasite growth and indi-
cate that the export of cholesterol from the 
late endocytic compartments is needed for 
normal P. berghei development.
The defect in autophagic flux in U18666A-treated or 
LAMP1/LAMP2-deficient cells is not likely responsible 
for restricted parasite development
In addition to their effect on cholesterol export from LEs and lyso-
somes, Npc mutations, U18666A treatment, or LAMP1/LAMP2-defi-
ciencies cause an increase in the steady-state number of LC3-II–posi-
tive autophagosomes due to a defect in amphisome formation 
(Tanaka et al., 2000; Eskelinen et al., 2004; Ishibashi et al., 2009; 
Sarkar et al., 2013; Maetzel et al., 2014). A similar accumulation of 
LC3-positive membranes can be observed in cells treated with 1 mM 
MβCD (Cheng et al., 2006; Supplemental Figure S4B). P. berghei 
liver-stage parasites growing in cells treated with MβCD showed no 
defect in development, suggesting that accumulation of autophagic 
bodies alone does not disturb parasite growth. Recently it was shown 
that LC3 is recruited to developing liver-stage parasites (Grützke 
et al., 2014; Prado et al., 2015; Boonhok et al., 2016; Thieleke-Matos 
et al., 2016). Published data also indicated that early recruitment of 
autophagy markers promotes successful liver-stage development 
(Prado et al., 2015). To examine further whether the impaired au-
tophagic flux seen in cells with impaired cholesterol transport could 
influence parasite growth, we monitored the recruitment of LC3 to 
developing liver-stage parasites over time in cells treated with 
U18666A. We saw no change in the recruitment of LC3 to liver-stage 
parasitophorous vacuoles in U18666A-treated Huh7 cells and only a 
very small difference in LAMP1/LAMP2-deficient MEFs compared 
with control cells (Supplemental Figure S4, D–F). Thus we have no 
evidence that the accumulation of autophagic bodies in the knock-
out and drug-treated cells alters the manner in which the parasite 
vacuole interacts with the host autophagy pathway or is responsible 
for the observed impairment of parasite growth.
Block of cholesterol export from late endocytic organelles 
affects liver-stage development and time to blood-stage 
patency in vivo
We sought to validate the in vitro data indicating the detrimental 
effect of cholesterol sequestration in LEs and lysosomes on 
P. berghei infection in vivo. To this end, we administered U18666A 
to C57BL/6 mice daily for 15 d, and after drug treatment on day 
15, we intravenously infected the mice with P. berghei sporozoites 
(Figure 6A). Blood-stage parasites were detected 3 d postinfection 
LEs and causes its accumulation in these compartments (Liscum and 
Faust, 1989; Roff et al., 1991). P. berghei growing in U18666A-
treated Huh7 cells reached ∼50% the size of parasites growing in 
control cells at 24 h postinfection (Figure 4A). This phenotype was 
confirmed in primary murine hepatocytes treated with U18666A 
(Figure 4A). To test potential activity of the drug against the para-
site, we pretreated sporozoites with U18666A under multiple condi-
tions before infection (Supplemental Figure S4A). This treatment 
caused no difference in liver-stage development compared with 
development of phosphate-buffered saline (PBS)–treated control 
sporozoites, which is consistent with the assumption that the effect 
of the drug on infection is due to disruption specifically of the host 
cell physiology.
We predict that the defects in parasite development in the 
LAMP1/LAMP2-deficient cells and the U18666A-treated cells is 
due to inhibition of the same host cellular pathways in both con-
ditions. If this assumption is true, combining these two condi-
tions through treatment of cells deficient in LAMP1 and LAMP2 
with U18666A should not have an additive effect and lead to 
further reduced parasite growth. When this was tested, indeed, 
U18666A treatment of Lamp1−/−Lamp2−/− cells resulted in para-
site growth that was similar to that seen in untreated Lamp1−/−L
amp2−/− cells or U18666A-treated wild-type cells (Figure 4B). 
These results are consistent with the hypothesis that LAMP defi-
ciency and U18666A treatment disrupt a common cellular path-
way important for parasite development, which further confirms 
that the effect of U18666A on infection is due to modulation of 
the host cell.
If the defect in parasite development upon U18666A treatment 
is due to the sequestration of cholesterol in LEs and lysosomes, we 
could predict, on the basis of previous studies (Rosenbaum et al., 
2010), that low concentrations of methyl-β-cyclodextrin (MβCD) 
should release the accumulated cholesterol and therefore restore 
parasite growth. Cyclodextrins are water-soluble compounds that 
can release cholesterol from membranes (Yancey et al., 1996; Atger 
et al., 1997), and MβCD efficiently reduces cholesterol accumulation 
in late endocytic compartments of cells with Npc mutations 
(Camargo et al., 2001; Lope-Piedrafita et al., 2008; Liu et al., 2009). 
In cells treated with U18666A alone, LAMP2-positive compart-
ments are enlarged (Supplemental Figure S4B), and cholesterol, as 
FIGURE 4: P. berghei development is impaired when host cell cholesterol export from late 
endocytic vacuoles is blocked. (A) Hepatoma cells and mouse primary hepatocytes or (B) WT 
and LAMP1/LAMP2-deficient MEFs were treated with 3 μM U18666A 12 h before and 
throughout infection with P. berghei sporozoites. Parasite size was assessed 24 h postinfection 
by fluorescence microscopy. Parasites were visualized by staining with anti-PbHsp70 antibody. 
One representative of at least three independent experiments is shown, with the exception of 
the experiment in primary hepatocytes, in which the combined results of two experiments are 
shown. ns, not significant; *p < 0.05, **p < 0.01 (Student’s unpaired t test, n = 3).
Volume 28 March 15, 2017 Host lysosomes and Plasmodium infection | 731 
drug-treated animals showed a strong filipin signal and a clear in-
crease in cholesterol accumulation in liver tissue. These data dem-
onstrate that functional cholesterol transport in host cells is required 
for efficient liver-stage growth of P. berghei also in vivo.
DISCUSSION
LEs and lysosomes fulfill many different functions in the endocytic 
network. The highly acidic vesicles are part of the cells’ antimicrobial 
defense mechanism, and their fusion with the PVM can lead to para-
site death (Prado et al., 2015, Boonhok et al., 2016). However, late 
endocytic vesicles are also a distribution point of substances taken 
up by the cells and could therefore serve as a nutrient source. Dur-
ing their development, liver-stage Plasmodium parasites undergo a 
striking size increase, for which they require large amounts of nutri-
ents, which they likely acquire from the nutrient-rich environment in 
the hepatocyte; however, our knowledge of the mechanisms by 
which the parasites acquire these resources from host cells is 
limited.
When we began our studies, the potential benefit of lysosomal 
recruitment to liver-stage parasites as a source of nutrients had been 
proposed (Lopes da Silva et al., 2012). However, this suggestion was 
based on the use of chemical agents that deacidify the lysosomes of 
not only the host cell, but also of the parasite, making interpretation 
of these data difficult. Recently it was shown that generation of 
phosphatidylinositol 3,5-bisphosphate by PIKfyve at endosomal 
membranes is required for efficient liver-stage parasite growth, 
which demonstrated that functions occurring at the host late endo-
cytic compartments are important for parasite growth (Thieleke-
Matos et al., 2014). Here we found that LEs/lysosomes are not effi-
ciently recruited to liver-stage-arrested uis4− parasites and that 
perturbing host LE/lysosome function reduced parasite burden. 
Together these results further support the hypothesis that LE/lyso-
some recruitment indicates proper PV maturation and may support 
parasite development.
What drives the association between late endocytic compart-
ments and the liver-stage PV is unknown. The presence of the au-
tophagy protein LC3 in the PVM may contribute to lysosomal re-
cruitment; however, because we showed that lysosomes are still 
recruited to the PV in ATG5-deficient cells, the interaction with the 
host autophagic pathway cannot be the sole factor responsible for 
lysosomal recruitment. Reduced recruitment of LEs/lysosomes to 
PVs containing uis4− parasites could be due to direct interaction 
between UIS4 and LE/lysosome membranes or proteins, or the 
cause could be indirect and instead due to improper maturation of 
the vacuole in the absence of UIS4. In either case, poor liver-stage 
growth, which has been demonstrated for uis4− parasites (Mueller 
et al., 2005), coincides with reduced recruitment of host LC3, LEs 
and lysosomes, and cholesterol. Although several PVM proteins 
have been shown to be important for parasite development, to our 
knowledge, this is the first example in which the absence of a para-
site protein is shown to alter the interaction between the PV and 
host cell. These results demonstrate that perturbing the protein 
composition of the PVM negatively affects the recruitment of host 
LEs during liver-stage development and suggest that accumulation 
of these organelles is a normal part of PV maturation.
To investigate whether host lysosomal functions contribute to 
liver-stage Plasmodium development, we assessed parasite growth 
in MEFs deficient for specific LE/lysosome proteins. Whereas 
ATP6V0A3 and ATP6AP2 are associated with the vacuolar-ATPase, 
which is responsible for lysosomal acidification, lysosomes remain 
acidified in both of these knockout lines (Kissing et al., 2015). 
Therefore, on the basis of our observation that cells deficient for 
in most control animals. However, U18666A-treated mice dis-
played a 2- to 3-d delay in patency, with blood-stage infection 
becoming apparent in most animals 5–6 d postinfection. This de-
lay is unlikely to be due to inhibition of blood-stage parasite repli-
cation because subsequent blood-stage replication proceeded 
normally in both groups (Supplemental Figure S5). To ensure that 
the delay in patency was due to liver-stage development, we as-
sessed the parasite burden in the livers of infected animals with a 
quantitative-PCR–based assay 42 h after infection (Figure 6B). 
Thus administration of U18666A resulted in a significant reduction 
of liver-stage parasite load and increased time to the appearance 
of P. berghei in the blood.
To confirm that U18666A influenced cholesterol transport in liv-
ers of treated mice, we visualized cholesterol in liver sections by fili-
pin staining and fluorescence microscopy (Figure 6C). Whereas in 
control livers, filipin intensities were weak and only a few areas with 
cholesterol accumulation could be detected, liver sections from 
FIGURE 5: Release of cholesterol from LE/lysosomes rescues 
P. berghei development in U18666A-treated cells. Huh7 cells were 
treated with 3 μM U18666A or 1 mM MβCD 36 h before infection. 
Where indicated, MβCD was added to U18666A-treated cells 12 h 
before infection. Cells were either fixed and stained with filipin 
(A; scale bars, 30 μm) or infected with P. berghei sporozoites and kept 
under continual presence of the drug until fixation 24 h postinfection 
(B). Parasites were visualized by staining with an anti-PbHsp70 
antibody. Size was assessed, and the area of each measured parasite 
was plotted individually. One representative of three independent 
experiments is shown. *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s 
unpaired t test, n = 3).
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Coxiella burnetii–containing phagosomes 
(Schulze-Luehrmann et al., 2016), and are 
less permissive to Trypanosoma cruzi inva-
sion (Albertti et al., 2010).
Autophagic flux is altered in cells defi-
cient for the LAMPs or NPC proteins and in 
cells treated with U18666A (Tanaka et al., 
2000; Eskelinen et al., 2004; Ishibashi et al., 
2009; Sarkar et al., 2013; Maetzel et al., 
2014). These cells display a defect in am-
phisome formation, which increases the 
number of steady-state autophagic bodies. 
Because the liver-stage PV is known to in-
teract with the autophagy pathway (Grützke 
et al., 2014; Prado et al., 2015; Thieleke-
Matos et al., 2016), we initially hypothe-
sized that defects in parasite growth in 
these conditions relate to changes in host 
autophagosome maturation. However, par-
asites grow robustly in cells treated with 
1 mM MβCD, which leads to a similar ac-
cumulation of autophagic bodies as seen in 
the aforementioned conditions. Furthermore, LC3 recruitment to 
liver-stage parasites is unchanged in U18666A-treated cells and 
barely reduced in LAMP-deficient cells. Thus, although we cannot 
rule out the possibility that alterations in autophagic maturation 
contribute to the parasite growth phenotypes we describe here, 
we have no evidence that autophagy is responsible for the P. ber-
ghei growth phenotypes.
The other shared phenotype caused by Npc mutations, Lamp 
mutations, and U18666A treatment is the sequestration of choles-
terol in late endocytic compartments. Cells can acquire cholesterol 
via two pathways: by uptake of LDL, which is hydrolyzed along the 
endocytic pathway and released from LEs to allow transport to other 
membranes in the cell, or via synthesis by the mevalonate pathway 
in the endoplasmic reticulum. In any of the conditions we tested in 
which cholesterol export from lysosomes is blocked, parasite growth 
was inhibited. We were able to validate these results in vivo by in-
fecting mice treated with U18666A. Of note, we could rescue the in 
vitro phenotype with MβCD. Cyclodextrins bind cholesterol and can 
extract it from membranes (Christian et al., 1997), and MβCD re-
duces cholesterol accumulation in late endocytic compartments of 
NPC-deficient cells and U18666A-treated cells and rescues the 
NPC-associated phenotype (Camargo et al., 2001; Lope-Piedrafita 
et al., 2008; Liu et al., 2009). These rescue experiments are per-
formed using 1 mM MβCD, which is 5–10 times less than the con-
centration typically used to deplete cholesterol from membranes. 
MβCD rescues the U18666A-induced phenotype by acting from 
within LEs (Abi-Mosleh et al., 2009; Rosenbaum et al., 2010), and an 
increase in esterified cholesterol has been detected in this context, 
indicating that this concentration of MβCD does not just remove 
cholesterol but makes it available for transport to the ER, the site of 
cholesterol esterification (Rosenbaum et al., 2010). It is therefore 
tempting to speculate that liver-stage Plasmodium grows poorly 
when cholesterol is sequestered in LEs because the parasite has re-
duced access to exogenously acquired cholesterol. Hepatocytes 
can compensate for deficits in cholesterol uptake through choles-
terol synthesis (Rudney and Sexton, 1986), but it is not sufficient to 
rescue the parasite growth phenotype.
Previous studies showed that host cholesterol labels the liver-
stage PVM and that both exogenous and endogenous sources con-
tribute to the cholesterol in these membranes (Labaied et al., 2011). 
ATP6V0A3 or ATP6AP2 support efficient parasite growth, we can-
not claim that acidification of host lysosomes is dispensable for 
parasite development, but only that these proteins are not required 
for parasite development. In contrast, cells deficient for NPC1, 
NPC2, LAMP1, or LAMP2 did not support proficient P. berghei 
growth in comparison to wild-type cells.
NPC2 is a small soluble protein in the LE/lysosome lumen, and 
NPC1 is a large membrane glycoprotein in the outer LE/lysosome 
membrane (Higgins et al., 1999; Naureckiene et al., 2000). The NPC 
proteins actively participate in cholesterol transport (Vanier and 
Millat, 2004), and mutation in either of these two genes leads to the 
lysosomal storage disease Niemann–Pick disease type C (Sokol 
et al., 1988). Other lipids, for example, sphingolipids, also accumu-
late in LEs/lysosomes of cells containing Npc mutations, but this is 
likely a consequence of the cholesterol sequestration (reviewed in 
Vance and Karten, 2014). Further, whereas sphingolipid levels are 
elevated in cells with Npc mutations (Chang et al., 2005), sphingo-
lipid levels in LAMP1/LAMP2 doubly deficient cells appear compa-
rable to those in wild-type cells (Eskelinen et al., 2004).
In infection studies, host NPC function has been found to be cru-
cial for the filoviruses Marburg and Ebola (Carette et al., 2011), as well 
as for HIV-1 infectivity and production (Tang et al., 2009; Coleman 
et al., 2012). Furthermore, the replication rate of Toxoplasma gondii 
is reduced in NPC-deficient cells (Coppens et al., 2000).
LAMP1 and LAMP2 are the most abundant proteins in mamma-
lian lysosomes. The exact function of these proteins is unknown, but 
characterization of cells and animals deficient for these proteins re-
veals their necessity for proper autophagosome maturation (Tanaka 
et al., 2000), phagosome maturation (Huynh et al., 2007), and cho-
lesterol egress from late endocytic compartments (Eskelinen et al., 
2004). These studies found that deletion of Lamp1 alone is compen-
sated for by increased expression of LAMP2 and therefore results in 
no severe phenotypes. In contrast, LAMP1 is not able to fully com-
pensate functionally for the loss of LAMP2. Accordingly, knockdown 
of Lamp1 did not affect Plasmodium infection, whereas knockdown 
of Lamp2 resulted in smaller developing parasites.
Previous infection studies in cells deficient for the LAMPs used 
pathogens that reside within LAMP-positive compartments during 
their development. LAMP1/LAMP2-deficient cells fail to kill Neisse-
ria gonorrhoeae (Binker et al., 2007), harbor faster-maturing, smaller 
FIGURE 6: Blocking cholesterol export from late endocytic organelles delays time to blood-
stage patency and reduces liver-stage parasite burden in vivo. Mice were treated daily with 
10 mg/kg U18666A (intraperitoneally) for 15 d before receiving an intravenous dose of 10,000 
P. berghei sporozoites. (A) The prepatent period was followed by microscopic examination of 
Giemsa-stained blood smears. (B) Parasite burden in infected mouse livers at 42 h postinfection 
was quantified by quantitative PCR. Relative expression levels of the Pb18S gene were 
normalized to expression levels of the mouse GAPDH gene. Data from two biological replicates 
(n = 3 and 5) are displayed. *p < 0,05 (Student’s unpaired t test; n = 8). (C) After treatment with 
U18666A for 15 d, mouse livers were removed and immediately frozen in liquid nitrogen. 
Sections (7 μm) were Formalin fixed, stained with filipin (0.05 mg/ml), and imaged under 
identical conditions.
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and hepatocyte wash medium (Life Technologies) and plated on 
collagen-coated dishes in William’s E Medium supplemented with 
10% fetal bovine serum and penicillin-streptomycin (Life Technolo-
gies). Wild-type P. berghei were either ANKA clone 507 (Janse 
et al., 2006) or ANKA Bergreen (Kooij et al., 2012), both of which 
express green fluorescent protein (GFP). The ibis1−P. berghei para-
site line was described previously (Ingmundson et al., 2012). The 
uis4− ANKA P. berghei was generated in clone 507 as described 
(Mueller et al., 2005). Anopheles stephensi mosquitoes were raised 
under a 14-h light/10-h dark cycle at 28°C and 80% humidity and 
were fed daily on 10% sucrose.
In vitro infections with P. berghei
Huh7 cells, MEFs, and primary hepatocytes seeded in collagen-
coated 96-well µclear plates (Greiner) were infected with P. berghei 
sporozoites as previously described (Silvie et al., 2008). When re-
quired, cells were treated as indicated in the figure legends with 3 
µM U18666A (Enzo Life Sciences; Liscum and Faust, 1989) and 1 µM 
MβCD (Sigma-Aldrich). Because the drugs are reversible (Härmälä 
et al., 1994; Rodal et al., 1999), they remained in the medium 
throughout infection. For merosome production, infection pro-
ceeded for 70 h; merosomes in the culture medium were harvested 
and counted in a Neubauer chamber.
Indirect immunofluorescence analysis
At the indicated time points, samples were fixed with 4% paraformal-
dehyde in PBS and permeabilized with either 100% ice-cold metha-
nol (for the LC3 antibody) or 0.3% Triton X-100 (all other antibodies) 
and labeled with the following primary antibodies: polyclonal chicken 
anti-GFP (1:1000; ab13970; Abcam), monoclonal mouse anti-Pb-
Hsp70 (Potocnjak et al., 1980), polyclonal rabbit anti-UIS4 (Müller 
et al., 2011), monoclonal mouse anti-LC3 (1:100; 5F10; Nanotools), 
polyclonal rabbit anti-EEA1 (1:500; ab2900; Abcam), monoclonal 
mouse anti-CD63 (1:100; CBL553; Merck Millipore), and mouse anti-
LAMP2 (1:500; H4B4; Developmental Studies Hybridoma Bank) fol-
lowed by Alexa Fluor–conjugated secondary antibodies (Invitrogen) 
and Hoechst 33342 (Invitrogen). When required, filipin staining was 
carried out before permeabilization using 0.025 mg/ml of filipin III 
(Sigma-Aldrich) in PBS for 1 h at room temperature.
Fluorescence microscopy, parasite quantification, 
and quantification of LE/lysosome recruitment
Fluorescent samples were analyzed using a Zeiss Axio Observer.Z1 
microscope (Zeiss) equipped with 10, 40, and 63×/1.2 oil immersion 
lens, and pictures were collected with an AxioCam MRm (Zeiss) and 
Zeiss AxioVision software (Zeiss). Images were processed in Fiji 
(Schindelin et al., 2012) or Adobe Photoshop.
The P. berghei liver-stage size (in micrometers squared) was mea-
sured in Fiji by identifying and measuring areas of fluorescence sig-
nal using defined threshold levels. The identified fluorescent areas 
were used to measure parasite area. Quantification of LE/lysosome 
recruitment was performed visually on stained samples. Parasites 
were considered to recruit LEs/lysosomes when a continuous por-
tion of the parasite periphery comprising at least 30% of the para-
site circumference had closely associated LAMP2- or CD63-positive 
vesicles. If <30% of the parasite was covered with these signals, the 
parasite was considered to not recruit these vesicles.
siRNA knockdown
Huh7 cells were reverse transfected with target-specific or control 
siRNAs (Silencer Select; Life Technologies) according to the manu-
facturer’s instructions. In brief, 24 h after cell seeding, siRNAs diluted 
Whereas cholesterol levels at the parasite PVM were shown to de-
crease when progesterone treatment blocked exogenous choles-
terol trafficking, parasite development was not investigated in this 
context (Labaied et al., 2011). Here we see that preventing release 
of late endocytic cholesterol has a negative effect on parasite devel-
opment. These results could be due to blocked access to choles-
terol by the parasite, which would indicate that blocking transfer of 
cholesterol out of late endosomes is more problematic for the para-
site than temporarily depleting the source of exogenous choles-
terol. Alterations in access to other late endocytic lipids could also 
contribute to the observed phenotypes. Cholesterol is not the only 
lipid species obtained by the parasite from the host cell. Acquisition 
of both lipoic acid (Deschermeier et al., 2012) and phosphatidylcho-
line (Itoe et al., 2014) from the host environment is needed for ro-
bust liver-stage parasite growth. The latter is present in LE mem-
branes but also in all other cellular membranes, so it seems unlikely 
that LEs and lysosomes would be the exclusive source of this lipid. 
However, transfer of this or other lipid species from LEs and lyso-
somes to the parasite or PVM could be altered when the cholesterol 
content of LE and lysosomes is increased.
Taken together, our results show that specific targeting of host 
LE/lysosomal proteins can restrict liver-stage parasite development. 
Because interfering with the lipid homeostasis in LEs interferes with 
parasite development, we conclude that proper host LE function ac-
tively contributes to successful parasite growth. Although fusion of 
lysosomes with the PVM can be a successful host defense against the 
parasite, we and others have provided evidence that these host late 
endocytic compartments positively contribute to parasite growth 
and that their close association with the PV and potential fusion with 
the liver-stage TVN could provide a source of lipids for the parasite 
during liver-stage development. Successful liver-stage parasites ap-
pear to maintain a balance between exploiting these degradative 
host compartments and avoiding their antiparasitic potential.
MATERIALS AND METHODS
Experimental animals, cells, and parasite lines
Female C57BL/6 and NMRI mice were obtained from Charles River 
Laboratories and were 6–12 wk of age at the time of experiments. 
All animal work was conducted in accordance with the German Tier-
schutzgesetz in der Fassung vom 18. Mai 2006 (BGBl. I S. 1207), 
which implements the Directive 86/609/EEC from the European 
Union and the European Convention for the protection of verte-
brate animals used for experimental and other scientific purposes. 
All appropriate measures were taken to reduce the pain or discom-
fort of the animals, and the protocol was approved by the ethics 
committee of the Max Planck Institute for Infection Biology and the 
Berlin state authorities (LAGeSo Reg# G0469/09 and G0294/15). 
The hepatoma cells used in this study were Huh7 cells cultured 
in RPMI supplemented with 10% fetal calf serum (FCS), 100 U 
penicillin, 100 µg/ml streptomycin, 2 mM l-glutamine, 10 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, and 1× nones-
sential amino acids (Life Technologies). MEFs including wild type, 
Npc−/− (Huang et al., 2014; kindly provided by Peter Lobel, Rutgers 
University, New Brunswick, NJ), Lamp1/2−/− (Eskelinen et al., 2004), 
Atg5−/− (Kuma et al., 2004; kindly provided by Ingo Schmitz, 
Helmholz Centre for Infection Research, Braunschweig, Germany), 
Atp6v0a3−/− (derived from the TCIRG1oc/oc line; Scimeca et al., 2000; 
Kissing et al., 2015); and Atp6ap2−/− (derived from the Atp6ap2 con-
ditional deletion line; Kissing et al., 2015) were maintained in DMEM 
supplemented with 10% FCS, 100 U penicillin, and 100 µg/ml strep-
tomycin. Primary murine hepatocytes were isolated from NMRI mice 
as described (Renia et al., 1990) using liver perfusion, liver digest, 
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in Opti-MEM (Life Technologies) and Lipofectamine RNAiMAX 
transfection solution (Life Technologies) were added to cells. At 
48 h after siRNA transfection, either knockdown efficiency was ana-
lyzed by Western blot using antibodies against LAMP1 (Abcam) and 
LAMP2 (Developmental Studies Hybridoma Bank) or cells were in-
fected with P. berghei sporozoites.
Quantification of liver parasite load by quantitative PCR
Quantification of parasite burden in mouse liver after sporozoite in-
fection into U18666A- or PBS-treated animals was performed as 
described (Friesen et al., 2010). Briefly, C57Bl/6 mice were injected 
intraperitoneally with 10 mg/kg U18666A in PBS or PBS alone daily 
for 15 d. On day 15, animals were injected with 104 sporozoites in-
travenously. At 42 h after infection, livers of infected animals were 
harvested and homogenized in TRIzol (Life Technologies), total RNA 
was extracted, and cDNA was prepared using the RETROscript re-
verse transcription kit (Life Technologies). Relative parasite levels 
were determined with quantitative PCR by comparing the mean Ct 
value of the P. berghei 18s ribosomal subunit to the mean Ct value 
of the Mus musculus GAPDH. To assess time to patency and parasit-
emia, Giemsa-stained blood smears were examined microscopically 
daily starting at day 3 after infection.
Staining of liver tissue sections
Liver tissue sections were generated from U18666A-treated and con-
trol animals. At 42 h postinfection, mice were killed and perfused with 
PBS. Livers were removed and frozen in liquid nitrogen immediately. 
Thin liver sections (7 µm) were stained with filipin as described (Vanier 
and Latour, 2015). Briefly, after fixing for 15 min in Formalin, sections 
were washed with PBS, and 0.05 mg/ml filipin was added to the sec-
tions for 1 h. Slides were mounted using ProLong Gold Antifade 
Mountant (Life Technologies) and examined using an Olympus BX50 
microscope. Images were processed in Fiji (Schindelin et al., 2012).
Statistical analysis
Statistics for parasite size analysis are based on the average values 
of three wells, not on the sizes of the individual parasites. All experi-
ments were carried out at least three times, with the exception of 
those in primary hepatocytes and in mice, which were both per-
formed twice. In each figure, one representative experiment is 
shown. All statistical analyses were performed using Prism 5.0 for 
Mac OS X (GraphPad Software, San Diego, CA). p < 0.05 was con-
sidered to indicate statistical significance.
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